November 2nd, 2023

Life Sciences BC seeks to raise the profile of our members and supporters, highlight their achievements, and promote BC's dynamic life sciences ecosystem. If you have news or a story to share, let us know. You can find previous editions of BioLinks newsletters and other resources on our website at News/Publications.

Oct. 30 was BC Non-Profit Day, celebrating the sector's significant economic and social impact. With their grassroots approach and responsiveness to community needs, NFPs deliver vital programs and services, uniquely positioning them to influence government policies, programs, and funding decisions.

We are proud to be one of the 31,000 non-profits in BC, collectively responsible for 335 jobs and contributing 28B dollars to the provincial economy. We also celebrate our fellow non-profit members for their invaluable contributions. Learn more. 

Please save the date for our LSBC Holiday Party on Dec.14 in Vancouver - details coming soon! Before that, however, we invite our Vancouver Island members to join us for our first-ever LSBC Vancouver Island Winter Social on Nov. 22 in beautiful Victoria! This event will bring sector leaders together for an enjoyable evening of networking and holiday festivities, graciously hosted by StarFish Medical. We hope to see you there! Learn more and register here.

Member Highlights 

Thanks to a generous $1M donation from Acuitas Therapeutics, BC Cancer is establishing a unique multi-disciplinary liver cancer program, addressing a disease that has traditionally received less attention than many other cancers. This significant contribution, the largest ever for liver cancer research in Canada, reflects Acuitas' commitment to supporting the crucial work at BC Cancer. Learn more.

CORCYM has shared a recent video published on CTSNET that demonstrates how the detachable head of its unique aortic cross-clamp, DeTACH, facilitates a robotic cardiac surgery procedure. Watch it here.

BCIT and LifeLabs have collaborated on an innovative addition to the Open Education Pathology Textbook. This new chapter is designed to improve understanding of the blood test process, including collection, processing, interpretation, and reporting results. It serves as a helpful resource for healthcare professionals and students globally. Learn more.

Dr. Harold Punnett of NervGen Pharma was recently featured on the Price of Business radio show, discussing the latest in reversing paralysis and nerve damage and NervGen's first human clinical trials for chronic and subacute spinal cord injury patients. Listen here.

New Members

FMRK Diagnostic Technologies Inc. is advancing and enabling decentralized diagnostic testing.  

Focal Lines Technologies enables healthier lifestyles by smarter materials. 

NovaSense Technology Ltd. provides smart sensing technology for pressure injury prevention.

Salyx Medical Inc. develops a wearable remote vitals monitoring system for geriatric wellness empowerment.

Tickit Health empowers behavioural healthcare through Digital Empathy™. 

Welcome all to the LSBC community!

Industry Highlights

Canada has announced a $15M investment, via funding from the CIHR, to create a groundbreaking Pan-Canadian Genome Library, which is set to revolutionize genomic data sharing across the country and increase researchers' and clinicians' understanding of health and disease, ultimately improving the health of people in Canada. The library will be hosted via SGEN, which includes the Michael Smith Genome Sciences Centre at BC Cancer in Vancouver. Learn more.

The Patented Medicine Prices Review Board (PMPRB) is launching the first phase of a public consultation on themes relevant to the development of new guidelines by inviting stakeholders to participate in a Policy Roundtable on December 5 (English session) and December 6 (French session). Learn more.

New provincial legislation, if passed, will remove regulatory barriers in BC and allow educated professionals from 29 professions, including engineers, teachers, and biologists, to seek credential recognition, no matter where they were trained. Learn more.

Canada has established an Implementation Advisory Group (IAG) as part of its first-ever National Strategy for Rare Diseases, announced earlier this year. This group will provide a platform for patients and stakeholders to offer patient-centred advice and share information and best practices related to rare diseases, ultimately guiding the implementation of the National Strategy. Learn more.

Canada's Minister of Innovation, Science and Industry of Canada, François-Philippe Champagne,

has congratulated the Advanced Manufacturing Cluster (NGen) on its recent funding renewal, now totalling $427M, that supports transformative projects in manufacturing. This unique model builds strong industry ecosystems, creating jobs, fostering growth, and positioning Canada as an innovation leader. Learn more.

Health Canada and the Public Health Agency of Canada have launched a new podcast, Healthy Canadians, featuring nuanced conversations and expert insights about various health topics. This can be found on YouTube or wherever you get your podcasts. 

Kudos

Congratulations to Tamer Mohamed of Aspect Biosystems, a winner of EY’s Entrepreneur of the Year 2023 Pacific region award for his work to help cure Type 1 diabetes and genetic and acquired liver diseases. Learn more about these awards and see the complete list of honourees here. Tamer discusses his journey with Aspect Biosystems in a recent BC Business article featuring the award winner. Read it here.  

Kudos to Santis Health on the first anniversary of the opening of its Vancouver office! The Santis team has grown to five people and supports a mix of local and national clients with public affairs, strategic advisory, policy, and communications advice. An exciting milestone!

Congratulations to UniQ Biotech for successfully securing a new US patent for the simultaneous detection of beta-HCG and Blood Glucose using innovative technology to revolutionize prenatal care by providing a convenient and accurate means of monitoring the health of pregnant women and their fetuses.

Applications Open

The Consulate General of Canada in Boston is offering a free virtual VC Bootcamp in early December for early-stage Canadian Life Sciences companies (those looking to do their first or an early Seed raise and have raised under $1M to date) seeking to improve their fundraising skills.

The program covers various life science sectors, including Biotech, MedTech, Digital Health, Diagnostics, and Drug Discovery. Topics include fundraising fundamentals, pitch coaching, IP/legal considerations, best practices, an overview of an online fundraising platform, due diligence, and pitch practice with investor feedback. The program spans approximately 8-10 weeks, requiring around 20 hours. To learn more, contact Philip.bunsick@international.gc.ca, and to download and submit an application, click here. 

To increase the number of medium and large businesses in BC, PacifiCan has launched a 3-year Business Acceleration Pilot designed to support the growth of businesses by providing access to capital and expert guidance. The application portal is available on the PacifiCan website, and the EOI deadline is Dec. 14. Learn more.

The Eureka Network, the world's largest public network dedicated to international cooperation in R&D and innovation, invites Canadian SMEs searching for research funding to respond to a call for proposals initiated by its Canadian funding body. They are seeking organizations engaged in international collaboration for innovative R&D projects. Applications are due Nov. 30. Learn more.

We invite you to explore our expanded list of current life sciences application opportunities by clicking the following link: Applications Open.

#ICYMI

Life Sciences BC is thrilled to announce our first LSBC Vancouver Island Winter Social on Nov. 22 in beautiful Victoria!

LSBC, in partnership with Biotech Primer, is pleased to present BioBasics 101: The Biology of Biotech for the Non-Scientist on Nov. 29/30.

Until next week,

Wendy and the LSBC team

AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023

AbCellera (Nasdaq: ABCL) announced that executives from the Company will present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023, at 4:30 p.m. Greenwich Mean Time (8:30 a.m. Pacific Time). A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the presentation... READ MORE

Scholar and Health Professional-Investigator Programs: 2024 Competitions Now Open

Michael Smith Health Research BC’s Scholar and Health Professional-Investigator (HP-I) awards provide funding to support BC’s health researchers in advancing science and improving the health of British Columbians. Applications are now open for our 2024 competitions. Through supporting outstanding health researchers, we help enable discovery-based research and the translation of that research to new treatments, cures, practices, and solutions that improve the health of British Columbians... READ MORE

Aspect Biosystems to Present New Preclinical Data on Bioprinted Liver Tissue Platform at Aasld the Liver Meeting® 2023

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, announced the presentation of new preclinical data on its bioprinted liver tissue platform at the The Liver Meeting® 2023, hosted by the American Association for the Study of Liver Diseases (AASLD), held in Boston, MA from November 10-14, 2023... READ MORE

Aurinia Response in Support of 2023 Updated Eular Recommendations for Management of Lupus and New Treatment Paradigm for Lupus Nephritis

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) – Aurinia welcomes the 2023 updated recommendations from The European Alliance of Associations for Rheumatology (EULAR) for the management of systemic lupus erythematosus (SLE) based on emerging new evidence, including a new treatment paradigm for lupus nephritis (LN)... READ MORE

Avantor® Reports Third Quarter 2023 Results

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, reported financial results for the third quarter ended September 30, 2023... READ MORE

Bausch Health Unveils “Looking Forward” – A New DTC Television Campaign for Seasonal Affective Disorder (SAD)

Bausch Health Companies Inc. (NYSE/TSX: BHC) announced the new release of “Looking Forward,” the television ad campaign for APLENZIN® (bupropion hydrobromide) extended-release tablets for individuals diagnosed with seasonal

affective disorder (SAD), a type of depression that follows a seasonal pattern. This represents the first-ever television commercial for a prescription medication indicated for the prevention of autumn-winter SAD. The ad is scheduled to run on connected TV including mid-October and throughout the winter months when SAD symptoms are most prevalent... READ MORE

Life Forward – Boehringer Ingelheim Unveils Its Evolved Company Brand

The evolved brand includes several striking changes including the introduction of a standout color palette and Boehringer Ingelheim’s first-ever brand claim “Life forward”. The claim builds on the foundation of the company purpose of ‘transforming lives for generations’ and emphasizes how the company behaves in response to present-day and future challenges and the impact it intends to make... READ MORE

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat

ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the presentation of updated dose escalation data from its Phase 1/2 study evaluating masofaniten (formerly EPI-7386) in combination with enzalutamide at the 30th Annual Prostate Cancer Foundation Scientific Retreat, taking place October 26-28, 2023, in Carlsbad, CA. Masofaniten is a first-in-class N-terminal domain androgen receptor (“AR”) inhibitor that suppresses androgen activity through a novel mechanism of action and is being developed for the treatment of prostate cancer... READ MORE

RBCx Steps up Support for Founders in Two High Growth Canadian Tech Segments to Fuel Startup Ecosystem Growth & Innovation (Nov.1)

RBCx, Royal Bank of Canada’s technology and innovation arm, is doubling down on its efforts to deliver tailored support for pre-seed and seed-stage tech founders, and entrepreneurs in life sciences – two highly specialized and rapidly growing segments within the Canadian tech ecosystem. Recognizing the unique needs of founders and scaling businesses in these segments, RBCx has strengthened its advisory bench with the appointment of four respected tech industry leaders to support clients in these spaces... READ MORE

Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress

All six patients in the first cohort (Cohort A) were successfully implanted with the 8-channel Cell Pouch System with post-transplant follow-up periods ranging from 6 months to 3.5 years; • 5 of 6 patients in Cohort A discontinued insulin therapy (insulin independent) following islet transplantation into the Cell Pouch and modest islet top-up via portal vein... READ MORE

High Insulin Levels Directly Linked to Pancreatic Cancer

The study, published in Cell Metabolism, provides the first detailed explanation of why people with obesity and type 2 diabetes are at an increased risk of pancreatic cancer. The research demonstrates that excessive insulin levels overstimulate pancreatic acinar cells, which produce digestive juices. This overstimulation leads to inflammation that converts these cells into precancerous cells... READ MORE

United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced that the first patient has enrolled in the registration-phase TETON PPFstudy, which will evaluate nebulized Tyvaso® (treprostinil) Inhalation Solution in 698 adult patients with progressive pulmonary fibrosis (PPF). This is in addition to two separate ongoing registration-phase studies, TETON 1 and TETON 2, of nebulized Tyvaso in patients with another type of pulmonary fibrosis (PF) known as idiopathic pulmonary fibrosis (IPF)... READ MORE

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced it will report its third quarter 2023 financial and operating results after the close of U.S. financial markets on Wednesday, November 8, 2023... READ MORE

Zymeworks Announces Participation In Upcoming Investor Conferences

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced that management will participate in the following upcoming investor conferences... READ MORE

IMC Interim President Announcement

"As I conclude my leadership of IMC on November 16th, I am thrilled to inform you that David Renwick is now the Interim President, Innovative Medicines Canada. I look forward to connecting David with our key partners in the coming weeks"... READ MORE

Avivo Biomedical Inc. Enters Into Know-How Agreement With Mayo Clinic for Advancement of Blood Type Conversion Technology for Organ Transplants

Avivo Biomedical Inc. (“Avivo”), a British Columbia-based preclinical-stage company, proudly announces a collaboration with Mayo Clinic through a know-how license agreement centering on Avivo’s technology for Enzyme-Converted type O (“ECO”) organs that is intended to improve the utilization of donor organs for transplantation... READ MORE

BC Cancer Establishes Liver Cancer Research Program with Donation from Acuitas Therapeutics

Around 3,500 Canadians are diagnosed with liver cancer each year and this number is increasing due to rising rates of viral hepatitis and obesity. Chronic liver damage from these factors destroys the organ’s unique ability to repair itself when damaged, which can then lead to cancer... READ MORE

Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress

David Epstein, Chief Executive Officer of Seagen said, “Seagen continues to build momentum in 2023 and delivered strong performance, marked by record quarterly net product sales, with significant year-over-year growth of 33%, contributing to total revenues of $649 million"... READ MORE

FDA Approves Cabtreo (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel For The Treatment Of Acne Vulgaris In Patients Twelve Years Of Age And Older

​Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its dermatology business, Ortho Dermatologics, announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, indicated for the topical treatment of acne vulgaris in patients twelve years of age and older... READ MORE

Kapoose Creek Wellness Ltd. is a Vancouver-based life sciences and natural health product development company, having its roots deep within the remote wilderness of Northwestern Vancouver Island, where the Pacific Ocean meets the Kapoose Creek estuary.

Kapoose is dedicated to the discovery, development and delivery of evidence-based functional and entheogenic mycologic (mushroom) pharmaceutical and natural products, and real-life therapeutic applications. LEARN MORE

Government of Canada invests $15M in first-of-its-kind Pan-Canadian Genome Library

Canada is a world-leader in genomic research—the study of all of a person’s or population’s genes. The field, which involves sequencing genomes to identify variations that give researchers a better understanding of health and disease, holds enormous potential for improving the health of Canadians... READ MORE

New Credential Legislation Will Get More People Working in Chosen Fields Quicker

The focus of the new credential legislation is fairness, efficiency, transparency and accountability. If passed, it will require regulatory bodies to remove barriers in 29 professions and make it easier and quicker for those qualified professionals to seek credential recognition, no matter where they were trained... READ MORE

Government of Canada Establishes Advisory Group to Help Canadians Living With Rare Diseases

As part of the first-ever National Strategy for Drugs for Rare Diseases announced in March 2023, the Government of Canada committed to establishing a national governance structure to support the implementation of the National Strategy and to help improve consistent access and affordability of effective drugs for rare diseases across the country.... READ MORE

Government of Canada Makes Biomanufacturing Investment to Boost Domestic Supply Chains

Canada needs to be able to deal with any future pandemics or health emergencies. That is why the Government of Canada, and the Government of Quebec, are investing in the revitalization of the Canadian biomanufacturing and life sciences sector with projects that strengthen our capabilities, while boosting the economy and creating or maintaining hundreds of well-paying jobs...READ MORE

PacifiCan Announces Launch of New Pilot Aimed At Helping BC Businesses Realize Their Growth Ambitions

Today, the Honourable Harjit S. Sajjan, Minister of Emergency Preparedness and Minister responsible for the Pacific Economic Development Agency of Canada (PacifiCan) announced the launch of PacifiCan’s Business Acceleration Pilot. This pilot aims to increase the number of medium- and large-sized businesses operating in B.C. by working with partners to accelerate the growth of existing small- and medium-sized businesses...READ MORE

Government of Canada Highlights Renewed Funding for the Advanced Manufacturing Cluster

Minister Champagne would like to congratulate the Advanced Manufacturing Cluster (NGen) on its recently renewed funding, which brings the total Government of Canada funding of the cluster to up to $427 million. This reinvestment in the cluster supports the commercialization of transformative projects that develop, scale up and apply advanced technology solutions in manufacturing, attracting talent and investments from within Canada and around the world...READ MORE

PMPRB Announces Next Steps in Guidelines Consultation Process

The Patented Medicine Prices Review Board (PMPRB) will launch the first phase of consultations on its new Guidelines by inviting stakeholders to participate in a Policy Roundtable on December 5 (English session) and December 6 (French session)...READ MORE

Research Associate II – Protein Sciences

As a Research Associate II in Protein Sciences within the Integrated Sciences group, your key responsibilities include supporting protein activities, assisting the antibody generation team, documenting results, collaborating across teams, and managing program timelines to advance therapeutic efforts. Join our motivated drug discovery team, dedicated to delivering transformative medicines to patients while fostering an innovative and collaborative environment...LEARN MORE

Research Associate II – Antibody Generation

As a Research Associate II in the Antibody Generation group, you'll be responsible for optimizing antibody generation platforms, identifying lead antibody candidates, collaborating across teams, documenting results, presenting data, supporting innovative research strategies, and fostering a culture of innovation and collaboration. Join our dedicated drug discovery team with a focus on delivering transformative medicines to patients...LEARN MORE

Associate Scientist – Molecular Biology, Integrated Sciences

As an Associate Scientist in the Integrated Sciences group, your key responsibilities involve developing innovative assay solutions, providing support to the antibody generation team, improving core platforms, documenting results, collaborating across functions, managing program timelines, and fostering innovation. We seek candidates passionate about innovation and technical challenges to join our motivated drug discovery team dedicated to delivering transformative medicines while maintaining a culture of respect and trust...LEARN MORE

Senior Scientist, Formulation

NanoVation Therapeutics (NTx) is looking for an innovative and collaborative Senior Scientist, Formulation to join our team. Reporting to the CSO, the Senior Scientist, Formulation will work closely with the Formulation Team and will be responsible for designing and executing protocols related to internal and client-based projects, and subsequent data analysis. Our ideal candidate thrives on contributing collaboratively in a fast-paced, innovative environment and is open and interested in learning a variety of different research techniques...LEARN MORE

Scientist, Preclinical Development

This is a full-time Scientist role on the Preclinical Development team at Integrated Nanotherapeutics Inc. involving work across multiple sites: headquarters in Burnaby, BC, with in vivo research activities and flow cytometry conducted at sites in Vancouver, BC and flexibility for some remote work. The successful candidate will contribute to our R&D programs in antigen-specific immune tolerance by applying in vivo mouse and cellular immunology skills to develop and advance lead lipid nanoparticle-based products through preclinical pipelines...LEARN MORE

Biomanufacturing Trainer and Site Manager

Reporting to the Associate Director of Technical Training they will take a leadership role in overseeing the set-up and operations of the greater Vancouver Training Facility and supporting the company’s overall strategy. As an expert in the field of biopharmaceutical manufacturing and bioprocessing, the Biomanufacturing Trainer/Site Lead will work with the Associate Director of Technical Training and other company team members to deliver world-class in-person, virtual and practical hands-on training to a variety of learners...LEARN MORE

Associate I

The QC Associate is responsible for performing routine samples analysis in accordance with GMP and Evonik policies and practices. The QC Associate will also assist with equipment calibration/qualification and analytical method validation, as well as participating in quality system improvement initiatives. This is a lab-based position which will entail a high volume of testing in a regulated laboratory environment...LEARN MORE

Senior Manager, Site Engagement Lead

The role involves leading strategic partnerships with key clinical trial sites, ensuring collaboration and operational efficiency, and serving as a subject matter expert. The responsibilities include maintaining strong relationships with sites, sharing insights, resolving issues, and centralizing operational information to enhance clinical trial execution, while also collaborating with internal stakeholders and contributing to process improvements...LEARN MORE

Principal Scientist/Associate Director Biologics

Abdera Therapeutics is seeking a highly motivated and skilled leader in antibody discovery with a proven track record of antibody campaigns. This position will provide an exciting and dynamic opportunity to positively contribute to and lead research programs and teams developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Mitacs Post-Doc

A postdoctoral position is available in the laboratory of Prof. Filip Van Petegem at the University of British Columbia. The goal is to apply state of the art computational protein design methods to create novel protein molecules to enable structural cryo-EM characterization of therapeutic candidates and their target. The project is a collaboration with Amgen, one of the world’s leading biotechnology companies, and is supported through a MITACS scholarship...LEARN MORE

Scientist, Clinical Pharmacokinetics

This role represents Clinical Pharmacology in multi-functional teams supporting late-stage discovery programs. It involves analyzing clinical PK data, assisting in study design, maintaining knowledge of drug development approaches, and contributing to regulatory and scientific documentation. The position also requires building client relationships, summarizing and presenting results, and coordinating with SAS programmers and Clinical Operations for efficient deliverables...LEARN MORE

Associate Scientist, In Vivo Pharmacology

This role involves overseeing in vivo immuno-oncology experiments, managing internal and external studies, and providing hands-on support for mouse handling and administrative tasks. It also encompasses pharmacodynamic evaluations, technology exploration, mentorship, result presentation, and ensuring compliance with scientific standards and regulations while promoting collaboration...LEARN MORE

Research Associate I, Analytics

The role involves conducting experiments, providing research support, and performing antibody/antigen purification through chromatography techniques. Additionally, it includes supporting protein characterizations, maintaining scientific standards, and fostering collaborative working relationships within the organization while adhering to safety regulations and documentation procedures. The position also entails maintaining a safe and organized laboratory environment and ensuring the procurement and organization of reagents and chemicals for the Analytics team...LEARN MORE

Quality System Specialist

To succeed in this role, the applicant must be a strong Quality partner/ collaborator to drive operational efficiencies to achieve sustainable quality compliance and meet the business objectives of the site. Build strong relationships with the Quality team, internal stakeholders (such as Development & Formulation, Supply Chain, Project Management, etc.) and external suppliers to assure on-time delivery of products/ materials/ services that are quality compliant and fit for its intended purpose...LEARN MORE

As an expert navigator of the Canadian health care, regulatory, and technology landscape, PHC Ventures provides indispensable support to corporate, institutional and individual innovators seeking to validate and commercialize their products and ideas. 

PHC Ventures offers a portal to Providence Health Care in Vancouver, Canada, a renowned provincial health organization whose lengthy innovation track record and size make it an ideal incubator to validate and scale innovations. PHC Ventures actively co-develops health solutions, forges unconventional partnerships, facilitates consulting relationships with PHC clinicians, and invests in health start-ups. LEARN MORE

Daniels Health is focused on delivering waste solutions that make sense from all standpoints of safety, sustainability, cost effectiveness and efficiency. We’re the first to admit that there are no two facilities alike; varying medical waste streams, waste volumes, segregation imperatives and limitations of space and movement – we get that “off the shelf” just simply does not work. Industry experts in the regulatory compliance and governance of collecting, transporting and treating all medical waste streams including sharps, biomedical, anatomical, cytotoxic, pharmaceutical waste and controlled substances, Daniels Health eliminates the need for multiple vendors. Across Canada, we are Making Healthcare Safer. LEARN MORE

FMRK is an emerging medical device company that aims to accelerate and enable decentralized healthcare through innovative, easy to use, point of care diagnostic tests. Using cutting edge technological advancements, we can reduce wait times in doctor’s offices and Emergency Rooms by creating viable alternative testing and treatment locations in community settings such as Pharmacies and Long Term Care Facilities. LEARN MORE

Focal Lines Technologies Inc. is a remote monitoring company dedicated to developing a user-friendly system that utilizes e-textile sensors to monitor and analyze vital muscle biofeedback.

Our primary goal is to provide support to individuals with neurological impairments, enabling them to remotely track their recovery process in their home settings. LEARN MORE

Stay current by subscribing to this and our events newsletter!

Follow LSBC on Social Media!